ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY

Abbott Rapid Diagnostics International Unlimited Company is a global health-technology organisation that creates diagnostic and medical-device solutions designed to improve patient outcomes and empower clinicians. Drawing on Abbott's broader portfolio, the company delivers rapid-test platforms and point-of-care systems that bring accurate results to the bedside, from glucose-monitoring programmes such as the Lingo Glucose System to sophisticated cardiac ablation tools like the Volt™ PFA Catheter, Sensor-Enabled™.

The firm's product range spans a variety of clinical areas, including diabetes management, cardiac electrophysiology and broader diagnostics testing. By integrating cutting-edge engineering with rigorous safety standards, Abbott's solutions aim to simplify complex workflows, reduce procedural risk and support healthier lives for millions of people worldwide. Their commitment to sustainability and community engagement underpins a purpose-driven approach, ensuring that the technology they develop not only advances medicine but also contributes positively to society.